Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C

BACKGROUND/AIMS: The present study aimed to clarify whether virological response within 2 weeks after therapy initiation can predict a null response to pegylated interferon α-2b plus ribavirin therapy in patients with high viral load genotype 1b hepatitis C. METHODS: The participants consisted of 72...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Yuki, Tamai, Hideyuki, Kawashima, Akira, Shingaki, Naoki, Mori, Yoshiyuki, Kawaguchi, Masanori, Moribata, Kosaku, Deguchi, Hisanobu, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Ichinose, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Gut and Liver 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113039/
https://www.ncbi.nlm.nih.gov/pubmed/25071908
http://dx.doi.org/10.5009/gnl.2014.8.4.421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113039/
https://www.ncbi.nlm.nih.gov/pubmed/25071908
http://dx.doi.org/10.5009/gnl.2014.8.4.421

Ejemplares similares